U.S. markets closed

Aquestive Therapeutics, Inc. (AQST)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.05+0.14 (+1.57%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 9/18/2020
Current
6/30/20203/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
299.55M163.21M73.55M145.75M79.64M104.90M
Enterprise Value 3
339.56M192.65M84.56M184.61M104.90M112.55M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
4.462.741.062.741.481.85
Price/Book (mrq)
N/AN/AN/AN/AN/AN/A
Enterprise Value/Revenue 3
5.738.899.6511.248.4510.11
Enterprise Value/EBITDA 6
-9.46159.21-6.57-20.26-6.97-6.32

Trading Information

Stock Price History

Beta (5Y Monthly) 3.72
52-Week Change 3187.30%
S&P500 52-Week Change 310.95%
52 Week High 310.00
52 Week Low 31.41
50-Day Moving Average 37.58
200-Day Moving Average 35.05

Share Statistics

Avg Vol (3 month) 3936.21k
Avg Vol (10 day) 31.53M
Shares Outstanding 533.62M
Float 27.69M
% Held by Insiders 113.68%
% Held by Institutions 157.50%
Shares Short (Aug 30, 2020) 41.53M
Short Ratio (Aug 30, 2020) 41.45
Short % of Float (Aug 30, 2020) 47.87%
Short % of Shares Outstanding (Aug 30, 2020) 44.56%
Shares Short (prior month Jul 30, 2020) 42.33M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin -84.20%
Operating Margin (ttm)-57.99%

Management Effectiveness

Return on Assets (ttm)-37.70%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)59.28M
Revenue Per Share (ttm)2.00
Quarterly Revenue Growth (yoy)94.80%
Gross Profit (ttm)32.25M
EBITDA -31.18M
Net Income Avi to Common (ttm)-49.91M
Diluted EPS (ttm)-1.68
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)25.42M
Total Cash Per Share (mrq)0.76
Total Debt (mrq)65.43M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.95
Book Value Per Share (mrq)-0.64

Cash Flow Statement

Operating Cash Flow (ttm)-49M
Levered Free Cash Flow (ttm)-27.36M